News|Videos|July 10, 2025
Junevity's Bold Move: Using siRNA to Fight Diabetes and Obesity
Author(s)Christopher Cole
Advertisement
In this quick clip from our BIO 2025 interview with Junevity Co-founder and CEO John Hoekman, PhD, Dr. Hoekman summarizes the potential of siRNA to fight diseases like diabetes and obesity.
Check out the full interview
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5